Johnson & Johnson Financial Statements (JNJ)

Johnson & Johnsonsmart-lab.ru %   2020 2021 2022 2022 2023   LTM ?
Report date 22.02.2021 17.02.2022 31.12.2022 16.02.2023 16.02.2024   23.10.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 82 584 78 740 94 943 79 990 85 159   88 772
Operating Income, bln rub 16 945 20 470 23 703 23 193 23 409   22 287
EBITDA, bln rub ? 27 498 30 925 21 939 27 170 23 725   31 579
Net profit, bln rub ? 14 714 20 878 17 941 17 941 35 153   13 329
OCF, bln rub ? 23 536 23 410 21 194 21 194 22 791   17 283
CAPEX, bln rub ? 3 347 3 652 4 009 4 009 4 543   4 062
FCF, bln rub ? 20 189 19 758 17 185 17 185 18 248   13 221
Dividend payout, bln rub 10 481 11 032 11 682 11 682 11 770   8 839
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%   0.00%
Dividend payout ratio, % 71.2% 52.8% 65.1% 65.1% 33.5%   66.3%
OPEX, bln rub 34 424 34 395 40 151 33 181 58 606   38 374
Cost of production, bln rub 28 427 23 402 31 089 24 596 26 553   27 126
R&D, bln rub 12 340 14 277 15 386 14 135 15 085   16 886
Interest expenses, bln rub 201.0 183.0 214.0 276.0 772.0   618.0
Assets, bln rub 174 894 182 018 187 378 187 378 167 558   178 287
Net Assets, bln rub ? 63 278 74 023 76 804 76 804 68 774   70 158
Debt, bln rub 35 266 33 751 39 659 39 642 29 332   35 751
Cash, bln rub 25 185 31 608 23 519 22 281 22 927   20 297
Net debt, bln rub 10 081 2 143 16 140 17 361 6 405   15 454
Ordinary share price, rub 157.4 171.1 176.7 176.7 156.7   150.2
Number of ordinary shares, mln 2 633 2 629 2 632 2 614 2 534   2 427
Market cap, bln rub 414 305 449 737 464 960 461 692 397 101   364 564
EV, bln rub ? 424 386 451 880 481 100 479 053 403 506   380 018
Book value, bln rub -26 517 -7 615 -16 752 2 268 -1 959   -14 131
EPS, rub ? 5.59 7.94 6.82 6.86 13.9   5.49
FCF/share, rub 7.67 7.52 6.53 6.58 7.20   5.45
BV/share, rub -10.1 -2.90 -6.36 0.87 -0.77   -5.82
EBITDA margin, % ? 33.3% 39.3% 23.1% 34.0% 27.9%   35.6%
Net margin, % ? 17.8% 26.5% 18.9% 22.4% 41.3%   15.0%
FCF yield, % ? 4.87% 4.39% 3.70% 3.72% 4.60%   3.63%
ROE, % ? 23.3% 28.2% 23.4% 23.4% 51.1%   19.0%
ROA, % ? 8.41% 11.5% 9.57% 9.57% 21.0%   7.48%
P/E ? 28.2 21.5 25.9 25.7 11.3   27.4
P/FCF 20.5 22.8 27.1 26.9 21.8   27.6
P/S ? 5.02 5.71 4.90 5.77 4.66   4.11
P/BV ? -15.6 -59.1 -27.8 203.6 -202.7   -25.8
EV/EBITDA ? 15.4 14.6 21.9 17.6 17.0   12.0
Debt/EBITDA 0.37 0.07 0.74 0.64 0.27   0.49
R&D/CAPEX, % 368.7% 390.9% 383.8% 352.6% 332.0%   415.7%
CAPEX/Revenue, % 4.05% 4.64% 4.22% 5.01% 5.33%   4.58%
Johnson & Johnson shareholders